Impact of pharmacist counselling on clozapine knowledge

Simple item page
dc.contributor.authorNí Dhubhlaing, Ciara
dc.contributor.authorYoung, Ailish
dc.contributor.authorSahm, Laura J.
dc.date.accessioned2018-06-15T11:47:13Z
dc.date.available2018-06-15T11:47:13Z
dc.date.issued2017
dc.description.abstractClozapine is the only antipsychotic with evidence for efficacy in treatment of resistant schizophrenia but it carries a high side effect burden. Patient information is provided but may be poorly retained. This study aims to examine the impact of pharmacist counselling upon patient knowledge of clozapine. Outpatients, aged 18 years and over, attending St. Patrick's University Hospital, Dublin, participated in this study between June and August 2015. The intervention consisted of pharmacist counselling on two occasions one month apart. Knowledge was assessed using a 28-point checklist devised from the currently available clozapine patient information sources, at baseline and after each counselling session. Ethics approval was obtained. Twenty-five participants (40% female; mean age 45.1 years, SD 9.82; 64% unemployed, 28% smokers) showed an improvement in knowledge scores of clozapine from baseline to postcounselling on each occasion with an overall improvement in knowledge score, from baseline to postcounselling at one month, of 39.43%; p < 0.001. This study adds to the evidence that interventions involving pharmacist counselling can improve patient knowledge, whilst the specific knowledge gained relating to recognition of side effects may help patients towards more empowerment regarding their treatment.en
dc.description.statusPeer reviewed
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.articleidUNSP 6120970
dc.identifier.citationNí Dhubhlaing, C., Young, A. and Sahm, L. J. (2017) 'Impact of pharmacist counselling on clozapine knowledge', Schizophrenia Research and Treatment, 2017, 6120970 (9pp). doi: 10.1155/2017/6120970en
dc.identifier.doi10.1155/2017/6120970
dc.identifier.endpage8
dc.identifier.issn2090-2085
dc.identifier.journaltitleSchizophrenia Research and Treatmenten
dc.identifier.startpage1
dc.identifier.urihttps://hdl.handle.net/10468/6335
dc.identifier.volume2017
dc.language.isoenen
dc.publisherHindawi Ltden
dc.relation.urihttps://www.hindawi.com/journals/schizort/2017/6120970
dc.rights© 2017, Ciara Ní Dhubhlaing et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectHealth literacyen
dc.subjectSchizophreniaen
dc.subjectMeta-analysisen
dc.subjectAdherenceen
dc.subjectAwarenessen
dc.subjectPatienten
dc.subjectRisken
dc.titleImpact of pharmacist counselling on clozapine knowledgeen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Impact of Pharmacist Counselling on Clozapine Knowledg.pdf
Size:
1.35 MB
Format:
Adobe Portable Document Format
Description:
Published Version
Download
Collections
Pharmacy - Journal Articles